CIK 0001808805
- Non-accelerated filer
- Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981541723
- Phone
- +1 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Senior VP, Product Development bought 15,000 shares at an average $2.03 ($30,399)
- 4 Open-market buy Chief People Officer bought 30,000 shares at $2.03 ($60,765)
- 4 Open-market buy Senior VP, Product Development bought 75,000 shares at an average $2.18 ($163,198)
- 4 Open-market buy CFO and Treasurer bought 17,500 shares at $2.30 ($40,219)
- 4 Open-market buy General Counsel bought 10,000 shares at an average $2.84 ($28,433)
- 4 Open-market buy CEO, President, and Secretary bought 50,000 shares at an average $2.92 ($146,090)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CFO and Treasurer bought 5,500 shares at $2.75 ($15,124)
Page 4 of 8 · 141 filings